Jeauveau (Newtox) announced something very exciting this past February. Can you guess what it could be? Yep, you know it. Jeuveau (pronounced Jū-vō) officially got the FDA seal of approval, making it the 4th product on the market resembling BOTOX. But, the more important question is, why is it different?
How does it stand out from its counterpart, Botox? Is it really worth the hype? It was specifically designed and marketed to be like Botox. With its sharp new vibe, it is targeted to appeal to the “softer” side of aesthetics. It doesn’t come with the possible negative connotations that Botox once got and it brings a whole new feel to the meaning of aesthetics and cosmetics. The main goal behind Newtox was to create the space for cosmetic spas and beauty spas to share common grounds.
As you could probably tell, Jeuveau can be hard for some to pronounce, so the company has coined it NewTox, an easier term for patients to understand and pronounce.
How will Newtox compare to Botox? We have to wait and see. It seems likely both of these products are great with consistent results. I think physician adoption (using it in our clinics) and patient feedback will likely determine the outcome. There’s no difference in the way it’s used. In fact, we can use it the same way we use Botox. Patients may not even notice a difference in terms of procedure!
So now that we get the basic idea about Newtox, have there been studies done on this Botox-like substance? The answer is yes.
Interestingly enough, the FDA actually required that the manufacturer of Newtox had to demonstrate that it performed as well as Botox, which it obviously passed quite easily. While it’s hard to yet say whether Newtox outperforms Botox over the course of several years, it’s definitely gotten a good head start.
However, there is one particular study that exists between the first generation Korean toxin product (Nabota) that preceded Jeuveau and Botox. In that study of the older formula, the Korean toxin slightly outperformed Botox in its cosmetic effects on patients.